Baolingbao Biology Co.,Ltd. (SHE:002286)

Baolingbao Biology Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	2,610	2,392	2,516	2,713	2,755	2,041
Other Revenue	5.57	9.46	7.65	-	9.9	13.19
Revenue	2,615	2,402	2,524	2,713	2,765	2,055
Revenue Growth (YoY)	7.72%	-4.84%	-6.96%	-1.89%	34.58%	13.82%
Cost of Revenue	2,291	2,123	2,326	2,404	2,397	1,868
Gross Profit	324.58	278.47	197.52	308.4	368.24	186.77
Selling, General & Admin	113.61	106.05	106.5	129.8	122.17	105.09
Research & Development	13.24	9.54	11.3	8.46	12.58	11.2
Other Operating Expenses	23.07	15.66	15.74	15.95	16.33	13.79
Operating Expenses	152.31	134.77	137.74	151.82	155.21	131.41
Operating Income	172.26	143.7	59.78	156.58	213.03	55.37
Interest Expense	-12.12	-13.04	-22.68	-26.54	-16.95	-13.18
Interest & Investment Income	6.74	6.9	7.36	7.97	18.85	8.35
Currency Exchange Gain (Loss)	6.64	6.64	1.61	12.17	-4.28	-6.71
Other Non Operating Income (Expenses)	-0.27	1.92	-3.09	-1.53	0.92	2.35
EBT Excluding Unusual Items	171.67	146.12	42.98	148.65	211.58	46.18
Gain (Loss) on Sale of Investments	-	-	-	2.61	11.23	-
Gain (Loss) on Sale of Assets	0	0.41	-0.05	-0.05	-	-0.07
Asset Writedown	-23.58	-22.56	0.01	-2.32	0.83	-0.07
Other Unusual Items	10.02	7.15	22.17	7.79	13.09	13.59
Pretax Income	158.12	131.11	65.11	156.69	236.74	59.63
Income Tax Expense	23.62	19.95	11.15	23.52	35.16	9.77
Earnings From Continuing Operations	134.5	111.16	53.97	133.17	201.58	49.86
Net Income	134.5	111.16	53.97	133.17	201.58	49.86
Net Income to Common	134.5	111.16	53.97	133.17	201.58	49.86
Net Income Growth	48.55%	105.97%	-59.47%	-33.94%	304.27%	41.52%
Shares Outstanding (Basic)	373	371	360	370	373	356
Shares Outstanding (Diluted)	373	371	360	370	373	356
Shares Change (YoY)	3.66%	2.99%	-2.74%	-0.91%	4.81%	1.08%
EPS (Basic)	0.36	0.30	0.15	0.36	0.54	0.14
EPS (Diluted)	0.36	0.30	0.15	0.36	0.54	0.14
EPS Growth	43.31%	100.00%	-58.33%	-33.33%	285.71%	40.00%
Free Cash Flow	58.21	58.79	130.05	-223.72	113.42	266.53
Free Cash Flow Per Share	0.16	0.16	0.36	-0.60	0.30	0.75
Dividend Per Share	0.095	0.095	0.080	0.080	0.060	0.060
Dividend Growth	18.75%	18.75%	-	33.33%	-	100.00%
Gross Margin	12.41%	11.59%	7.83%	11.37%	13.32%	9.09%
Operating Margin	6.59%	5.98%	2.37%	5.77%	7.70%	2.70%
Profit Margin	5.14%	4.63%	2.14%	4.91%	7.29%	2.43%
Free Cash Flow Margin	2.23%	2.45%	5.15%	-8.25%	4.10%	12.97%
EBITDA	294.29	261.84	177.62	258.01	318.01	151.63
EBITDA Margin	11.25%	10.90%	7.04%	9.51%	11.50%	7.38%
D&A For EBITDA	122.02	118.14	117.84	101.43	104.98	96.26
EBIT	172.26	143.7	59.78	156.58	213.03	55.37
EBIT Margin	6.59%	5.98%	2.37%	5.77%	7.70%	2.70%
Effective Tax Rate	14.94%	15.22%	17.12%	15.01%	14.85%	16.38%
Revenue as Reported	2,615	2,402	2,524	2,713	2,765	2,055
Advertising Expenses	-	1.87	2.62	2.64	1.15	1.35

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.